Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma

Inhaled rhIL-15 combined with amputation and chemotherapy is associated with worse outcomes in dogs with OSA. Correlative assays suggest significant immunological effects of amputation and chemotherapy on immune responses. These data have important implications on novel immunotherapy strategies involving multimodality approaches including surgery and chemotherapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-10-23
DOI
https://doi.org/10.3389/fimmu.2025.1672790
Primary Topic
Immune Cell Function and Interaction
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma

Daniel York, Michael S. Kent, Anthony E. Zamora, Timothy M. Fan et al.
Frontiers in Immunology
Immune Cell Function and Interaction
article

Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcoma

Daniel York, Michael S. Kent, Anthony E. Zamora, Timothy M. Fan, Tamar Cohen‐Davidyan, Amy K. LeBlanc, Jessica A. Beck, Amandine Lejeune, Cyrus J. Sholevar, William J. Murphy, Ravi K. Shah, David M. Vail, Madison E. Luker, William T. N. Culp, Aryana M. Razmara, Jenna H. Burton, Christina Mazcko, Kevin Woolard, Robert B. Rebhun, Sylvia M. Cruz, Susan L. Stewart, Sushant Patkar, Katherine A. Skorupski, Robert J. Canter, Sean J. Judge, Sami Al‐Nadaf, Ellen E. Sparger, Erich Huang, Jacque C. Young
article en

Abstract

Inhaled rhIL-15 combined with amputation and chemotherapy is associated with worse outcomes in dogs with OSA. Correlative assays suggest significant immunological effects of amputation and chemotherapy on immune responses. These data have important implications on novel immunotherapy strategies involving multimodality approaches including surgery and chemotherapy.

Frontiers in ImmunologyVol. 16
National Institutes of Health (US), Urbana University (US), Medical College of Wisconsin (US), Veterinary Medical Teaching Hospital (US), University of Wisconsin Carbone Cancer Center (US), National Cancer Institute (MY), National Cancer Institute (US), University of California Davis Medical Center (US), University of California, Davis (US), Colorado State University (US)
Frederick National Laboratory for Cancer Research, National Institutes of Health, University of California, Davis, National Cancer Institute
Openalex Percentile: Top 69%
Immune Cell Function and Interaction
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.